Aqr Capital Management LLC Fulgent Genetics, Inc. Transaction History

Aqr Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $1.43 Million - $1.76 Million	-48,502 Reduced 30.04%	112,949 $3.53 Million
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $1.92 Million - $2.65 Million	65,682 Added 68.58%	161,451 $4.81 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $2.14 Million - $3.61 Million	56,562 Added 144.27%	95,769 $3.65 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $231,455 - $302,706	4,824 Added 14.03%	39,207 $2.14 Million
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $966,342 - $1.86 Million	19,385 Added 129.25%	34,383 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $225,406 - $306,180	2,916 Added 24.14%	14,998 $1.51 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $92,913 - $137,589	-1,241 Reduced 9.31%	12,082 $1.09 Million
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $430,459 - $647,299	6,444 Added 93.68%	13,323 $1.23 Million
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $191,064 - $592,364	-3,222 Reduced 31.9%	6,879 $665,000
Q4 2020 Feb 16, 2021	SELL	$31.01 - $52.1 $120,752 - $202,877	-3,894 Reduced 27.82%	10,101 $526,000
Q3 2020 Nov 16, 2020	BUY	$15.89 - $50.51 $222,380 - $706,887	13,995 New	13,995 $560,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.